- Croxatto A, Dijkstra K, Prod’hom G, Greub G. Comparison of Inoculation with the InoqulA and WASP Automated Systems with Manual Inoculation. Journal of Clinical Microbiology. 2015;53(7):2298-2307. DOI: 10.1128/JCM.03076-14.
- Yue P, Zhou M, Zhang L, et al. Clinical Performance of BD Kiestra™ InoqulA Automated System in a Chinese Tertiary Hospital. Infect Drug Resist. 2020 Apr 1;13:941-947. DOI: 10.2147/IDR.S245173
- Graham M, Tilson L, Streitberg R, Hamblin J, Korman TM. Improved standardization and potential for shortened time to results with BD Kiestra™ Total Laboratory Automation of early urine cultures: A prospective comparison with manual processing. Diagn Microbiol Infect Dis. 2016 Sep;86(1):1-4. DOI: 10.1016/j.diagmicrobio.2016.06.020.
- Iversen et al. Comparative evaluation of inoculation of urine samples with the Copan WASP and BD Kiestra™ InoqulA instruments. J Clin Microbiol. 2016;54(2):328-332. DOI: 10.1128/JCM.01718-15
- Ledeboer N et al. The automated clinical microbiology laboratory: fact or fantasy? J Clin Microbiol. 2014;52(9):3140-3146. DOI: 10.1128/JCM.00686-14.
- Thomson Rb, McElvania E. Total Laboratory Automation. Clin Lab Med. 2019;39(3):371-389. DOI: 10.1016/j.cll.2019.05.002.
Based on studies of urine cultures with selected organisms.
**Comparison of the BD Kiestra™ InoqulA and the Copan WASP® Automated Systems with manual inoculation
Disclaimer:
This business has been acquired by Waters Corporation (“Waters”). For products referenced on this page, the legal manufacturer remains Becton, Dickinson and Company or one of its affiliates or subsidiaries (“BD”) until all required regulatory transfers are completed. During this interim period, BD maintains full responsibility for all regulatory obligations of the legal manufacturer. Product information provided here is supplied under the regulatory authority of BD. To learn more about the relationship between Waters and BD during this transition period, please see our detailed summary waters.com/bdtransaction.